We studied the frequency with which unexplained oral candidiasis led to unequivocal acquired immunodeficiency syndrome (AIDS) in patients at risk. Twenty-two previously healthy adults with unexplained oral candidiasis, of whom the 19 tested had a reversed T4/T8 ratio and 20 had generalized lymphadenopathy, were compared with 20 similar patients with a reversed T4/T8 ratio and generalized lymphadenopathy who did not have oral candidiasis. All were intravenous-drug abusers, homosexual or bisexual men, or both. Thirteen of the 22 patients with oral candidiasis (59 per cent) acquired a major opportunistic infection or Kaposi's sarcoma at a median of three months (range, 1 to 23) as compared with none of 20 patients with generalized lymphadenopathy and immunodeficiency but without candidiasis who were followed for a median of 12 months (range, 5 to 21) (P less than 0.001). AIDS developed in 12 of 15 patients with candidiasis and T4/T8 ratios less than or equal to 0.51, as compared with none of four with ratios equal to or greater than 0.60 (P less than 0.01). We conclude that in patients at high risk for AIDS, the presence of unexplained oral candidiasis predicts the development of serious opportunistic infections more than 50 per cent of the time. Whether the remainder will have AIDS is not yet known.
This article has been cited by other articles:
Stone, V. E., Bounds, B. C., Muse, V. V., Ferry, J. A.
(2009). Case 29-2009 -- An 81-Year-Old Man with Weight Loss, Odynophagia, and Failure to Thrive. NEJM
361: 1189-1198
[Full Text]
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., Filler, S. G., Masso-Welch, P., Edgerton, M., Gaffen, S. L.
(2009). Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. JEM
206: 299-311
[Abstract][Full Text]
Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhauser, J., Rogers, P. D.
(2008). A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate. Eukaryot Cell
7: 1180-1190
[Abstract][Full Text]
Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhauser, J., Nantel, A., Raymond, M., Rogers, P. D.
(2007). Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon. Eukaryot Cell
6: 2122-2138
[Abstract][Full Text]
Leigh, J. E., McNulty, K. M., Fidel, P. L. Jr.
(2006). Characterization of the Immune Status of CD8+ T Cells in Oral Lesions of Human Immunodeficiency Virus-Infected Persons with Oropharyngeal Candidiasis. CVI
13: 678-683
[Abstract][Full Text]
Challacombe, S.J., Naglik, J.R.
(2006). The Effects of HIV Infection on Oral Mucosal Immunity. ADR
19: 29-35
[Abstract][Full Text]
Hodgson, T.A., Greenspan, D., Greenspan, J.S.
(2006). Oral Lesions of HIV Disease and HAART in Industrialized Countries. ADR
19: 57-62
[Abstract][Full Text]
Hodgson, T.A., Naidoo, S., Chidzonga, M., Ramos-Gomez, F., Shiboski, C.
(2006). (A1) Identification of Oral Health Care Needs in Children and Adults, Management of Oral Diseases. ADR
19: 106-117
[Abstract][Full Text]
McNulty, K. M., Plianrungsi, J., Leigh, J. E., Mercante, D., Fidel, P. L. Jr.
(2005). Characterization of CD8+ T Cells and Microenvironment in Oral Lesions of Human Immunodeficiency Virus-Infected Persons with Oropharyngeal Candidiasis. Infect. Immun.
73: 3659-3667
[Abstract][Full Text]
de Repentigny, L., Lewandowski, D., Jolicoeur, P.
(2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev.
17: 729-759
[Abstract][Full Text]
Hooshdaran, M. Z., Barker, K. S., Hilliard, G. M., Kusch, H., Morschhauser, J., Rogers, P. D.
(2004). Proteomic Analysis of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother.
48: 2733-2735
[Abstract][Full Text]
Chattopadhyay, A., Gray, L. R., Patton, L. L., Caplan, D. J., Slade, G. D., Tien, H.-C., Shugars, D. C.
(2004). Salivary Secretory Leukocyte Protease Inhibitor and Oral Candidiasis in Human Immunodeficiency Virus Type 1-Infected Persons. Infect. Immun.
72: 1956-1963
[Abstract][Full Text]
Polonelli, L., Magliani, W., Conti, S., Bracci, L., Lozzi, L., Neri, P., Adriani, D., De Bernardis, F., Cassone, A.
(2003). Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis. Infect. Immun.
71: 6205-6212
[Abstract][Full Text]
Rogers, P. D., Barker, K. S.
(2003). Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother.
47: 1220-1227
[Abstract][Full Text]
Kamai, Y., Kubota, M., Fukuoka, T., Kamai, Y., Maeda, N., Hosokawa, T., Shibayama, T., Uchida, K., Yamaguchi, H., Kuwahara, S.
(2003). Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice. Antimicrob. Agents Chemother.
47: 601-606
[Abstract][Full Text]
Myers, T. A., Leigh, J. E., Arribas, A. R., Hager, S., Clark, R., Lilly, E., Fidel, P. L. Jr.
(2003). Immunohistochemical Evaluation of T Cells in Oral Lesions from Human Immunodeficiency Virus-Positive Persons with Oropharyngeal Candidiasis. Infect. Immun.
71: 956-963
[Abstract][Full Text]
Nomanbhoy, F., Steele, C., Yano, J., Fidel, P. L. Jr.
(2002). Vaginal and Oral Epithelial Cell Anti-Candida Activity. Infect. Immun.
70: 7081-7088
[Abstract][Full Text]
Rogers, P. D., Barker, K. S.
(2002). Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis. Antimicrob. Agents Chemother.
46: 3412-3417
[Abstract][Full Text]
Santoni, G., Boccanera, M., Adriani, D., Lucciarini, R., Amantini, C., Morrone, S., Cassone, A., De Bernardis, F.
(2002). Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4+ T Cells and Possible Participation of Other Local Lymphocyte Effectors. Infect. Immun.
70: 4791-4797
[Abstract][Full Text]
de Meeus, T., Renaud, F., Mouveroux, E., Reynes, J., Galeazzi, G., Mallie, M., Bastide, J. M.
(2002). Genetic Structure of Candida glabrata Populations in AIDS and Non-AIDS Patients. J. Clin. Microbiol.
40: 2199-2206
[Abstract][Full Text]
Blignaut, E., Pujol, C., Lockhart, S., Joly, S., Soll, D. R.
(2002). Ca3 Fingerprinting of Candida albicans Isolates from Human Immunodeficiency Virus-Positive and Healthy Individuals Reveals a New Clade in South Africa. J. Clin. Microbiol.
40: 826-836
[Abstract][Full Text]
Steele, C., Fidel, P. L. Jr.
(2002). Cytokine and Chemokine Production by Human Oral and Vaginal Epithelial Cells in Response to Candida albicans. Infect. Immun.
70: 577-583
[Abstract][Full Text]
Farah, C. S., Elahi, S., Drysdale, K., Pang, G., Gotjamanos, T., Seymour, G. J., Clancy, R. L., Ashman, R. B.
(2002). Primary Role for CD4+ T Lymphocytes in Recovery from Oropharyngeal Candidiasis. Infect. Immun.
70: 724-731
[Abstract][Full Text]
Kamai, Y., Kubota, M., Kamai, Y., Hosokawa, T., Fukuoka, T., Filler, S. G.
(2001). New Model of Oropharyngeal Candidiasis in Mice. Antimicrob. Agents Chemother.
45: 3195-3197
[Abstract][Full Text]
Steele, C., Leigh, J., Swoboda, R., Ozenci, H., Fidel, P. L. Jr.
(2001). Potential Role for a Carbohydrate Moiety in Anti-Candida Activity of Human Oral Epithelial Cells. Infect. Immun.
69: 7091-7099
[Abstract][Full Text]
Farah, C. S., Elahi, S., Pang, G., Gotjamanos, T., Seymour, G. J., Clancy, R. L., Ashman, R. B.
(2001). T Cells Augment Monocyte and Neutrophil Function in Host Resistance against Oropharyngeal Candidiasis. Infect. Immun.
69: 6110-6118
[Abstract][Full Text]
Lott, T. J., Effat, M. M.
(2001). Evidence for a more recently evolved clade within a Candida albicans North American population. Microbiology
147: 1687-1692
[Abstract][Full Text]
Choi, J. H., Ko, H. M., Kim, J.-W., Lee, H.-K., Han, S. S., Chun, S.-B., Im, S. Y.
(2001). Platelet-Activating Factor-Induced Early Activation of NF-{{kappa}}B Plays a Crucial Role for Organ Clearance of Candida albicans. J. Immunol.
166: 5139-5144
[Abstract][Full Text]
La Valle, R., Sandini, S., Gomez, M. J., Mondello, F., Romagnoli, G., Nisini, R., Cassone, A.
(2000). Generation of a Recombinant 65-Kilodalton Mannoprotein, a Major Antigen Target of Cell-Mediated Immune Response to Candida albicans. Infect. Immun.
68: 6777-6784
[Abstract][Full Text]
Torosantucci, A., Chiani, P., Cassone, A.
(2000). Differential chemokine response of human monocytes to yeast and hyphal forms of Candida albicans and its relation to the {beta}-1,6 glucan of the fungal cell wall. J. Leukoc. Biol.
68: 923-932
[Abstract][Full Text]
Chapple, I. L C, Hamburger, J.
(2000). The significance of oral health in HIV disease. Sex. Transm. Infect.
76: 236-243
[Full Text]
de Bernardis, F., Santoni, G., Boccanera, M., Spreghini, E., Adriani, D., Morelli, L., Cassone, A.
(2000). Local Anticandidal Immune Responses in a Rat Model of Vaginal Infection by and Protection against Candida albicans. Infect. Immun.
68: 3297-3304
[Abstract][Full Text]
Andrutis, K. A., Riggle, P. J., Kumamoto, C. A., Tzipori, S.
(2000). Intestinal Lesions Associated with Disseminated Candidiasis in an Experimental Animal Model. J. Clin. Microbiol.
38: 2317-2323
[Abstract][Full Text]
Jones-Carson, J., Vazquez-Torres, A., Warner, T., Balish, E.
(2000). Disparate Requirement for T Cells in Resistance to Mucosal and Acute Systemic Candidiasis. Infect. Immun.
68: 2363-2365
[Abstract][Full Text]
Gomez, M. J., Maras, B., Barca, A., La Valle, R., Barra, D., Cassone, A.
(2000). Biochemical and Immunological Characterization of MP65, a Major Mannoprotein Antigen of the Opportunistic Human Pathogen Candida albicans. Infect. Immun.
68: 694-701
[Abstract][Full Text]
Xu, J., Boyd, C. M., Livingston, E., Meyer, W., Madden, J. F., Mitchell, T. G.
(1999). Species and Genotypic Diversities and Similarities of Pathogenic Yeasts Colonizing Women. J. Clin. Microbiol.
37: 3835-3843
[Abstract][Full Text]
Lin, A. L., Shi, Q., Johnson, D. A., Patterson, T. F., Rinaldi, M. G., Yeh, C.-K.
(1999). Further Characterization of Human Salivary Anticandidal Activities in a Human Immunodeficiency Virus-Positive Cohort by Use of Microassays. CVI
6: 851-855
[Abstract][Full Text]
Lopez-Ribot, J. L., McAtee, R. K., Kirkpatrick, W. R., La Valle, R., Patterson, T. F.
(1999). Low Levels of Antigenic Variability in Fluconazole-Susceptible and -Resistant Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis. CVI
6: 665-670
[Abstract][Full Text]
Lopez-Ribot, J. L., McAtee, R. K., Perea, S., Kirkpatrick, W. R., Rinaldi, M. G., Patterson, T. F.
(1999). Multiple Resistant Phenotypes of Candida albicans Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother.
43: 1621-1630
[Abstract][Full Text]
de Bernardis, F., Mondello, F., Scaravelli, G., Pachì, A., Girolamo, A., Agatensi, L., Cassone, A.
(1999). High Aspartyl Proteinase Production and Vaginitis in Human Immunodeficiency Virus-Infected Women. J. Clin. Microbiol.
37: 1376-1380
[Abstract][Full Text]
Vazquez-Torres, A., Jones-Carson, J., Wagner, R. D., Warner, T., Balish, E.
(1999). Early Resistance of Interleukin-10 Knockout Mice to Acute Systemic Candidiasis. Infect. Immun.
67: 670-674
[Abstract][Full Text]
Radford, D.R., Challacombe, S., Walter, J.D.
(1999). Denture Plaque and Adherence of Candida Albicans To Denture-Base Materials in Vivo and in Vitro. CROBM
10: 99-116
[Abstract][Full Text]
Vora, S., Purimetla, N., Brummer, E., Stevens, D. A.
(1998). Activity of Voriconazole, a New Triazole, Combined with Neutrophils or Monocytes against Candida albicans: Effect of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor. Antimicrob. Agents Chemother.
42: 907-910
[Abstract][Full Text]
Herzyk, D. J., Ruggieri, E. V., Cunningham, L., Polsky, R., Herold, C., Klinkner, A. M., Badger, A., Kerns, W. D., Bugelski, P. J.
(1997). Single-Organism Model of Host Defense against Infection: A Novel Immunotoxicologic Approach to Evaluate Immunomodulatory Drugs. Toxicol Pathol
25: 351-362
[Abstract]
Shiboski, C. H., Hilton, J. F., Neuhaus, J. M., Canchola, A., Greenspan, D., University of California, San Francisco Oral AIDS,
(1996). Human Immunodeficiency Virus--Related Oral Manifestations and Gender: A Longitudinal Analysis. Arch Intern Med
156: 2249-2254
[Abstract]
Currie, P. F, Jacob, A. J, Foreman, A. R, Elton, R. A, Brettle, R. P, Boon, N. A
(1994). Heart muscle disease related to HIV infection: prognostic implications. BMJ
309: 1605-1607
[Abstract][Full Text]
Rabeneck, L., Wray, N. P.
(1993). Predicting the Outcomes of Human Immunodeficiency Virus Infection: How Well Are We Doing?. Arch Intern Med
153: 2749-2755
[Abstract]
Ficarra, G., Shillitoe, E.J.
(1992). HIV-Related Infections of the Oral Cavity. CROBM
3: 207-231
[Abstract][Full Text]
Smith, P. D., Quinn, T. C., Strober, W., Janoff, E. N., Masur, H.
(1992). Gastrointestinal Infections in AIDS. ANN INTERN MED
116: 63-77
[Abstract]
Gottlieb, M. S., Zackin, R. A., Fiala, M., Henry, D. H., Marcel, A. J., Combs, K. L., Vieira, J., Liebman, H. A., Cone, L. A., Hillman, K. S., Gottlieb, A. A.
(1991). Response to Treatment with the Leukocyte-derived Immunomodulator IMREG-1 in Immunocompromised Patients with AIDS-related Complex: A Multicenter, Double-Blind, Placebo-Controlled Trial. ANN INTERN MED
115: 84-91
[Abstract]
Cockerell, C. J.
(1991). Human Immunodeficiency Virus Infection and the Skin: A Crucial Interface. Arch Intern Med
151: 1295-1303
[Abstract]
Katz, M. H., Baron, R. B., Grady, D.
(1991). Risk Stratification of Ambulatory Patients Suspected of Pneumocystis Pneumonia. Arch Intern Med
151: 105-110
[Abstract]
Schulten, E. A. J. M., ten Kate, R. W., van der Waal, I.
(1990). The Impact of Oral Examination on the Centers for Disease Control Classification of Subjects With Human Immunodeficiency Virus Infection. Arch Intern Med
150: 1259-1261
[Abstract]
Mirth, D.B., Bartkiewicz, A., Shern, R.J., Little, W.A.
(1989). Development and in vitro Evaluation of an Intra-oral Controlled-release Delivery System for Chlorhexidine. JDR
68: 1285-1288
[Abstract]
Stoneburner, R., Des Jarlais, D., Benezra, D, Gorelkin, L, Sotheran, J., Friedman, SR, Schultz, S, Marmor, M, Mildvan, D, Maslansky, R
(1988). A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science
242: 916-919
[Abstract]
Murray, H. W., Scavuzzo, D. A., Kelly, C. D., Rubin, B. Y., Roberts, R. B.
(1988). T4+ Cell Production of Interferon Gamma and the Clinical Spectrum of Patients at Risk for and With Acquired Immunodeficiency Syndrome. Arch Intern Med
148: 1613-1616
[Abstract]
DIAZ, J. D., BERMAN, A., LOCKEY, R. F., ESPINOZA, L. R.
(1988). Classification Systems for Human Immunodeficiency Virus (HIV) Infection. ANN INTERN MED
108: 155-156
[Abstract]
Rhoads, J. L., Wright, D. C., Redfield, R. R., Burke, D. S.
(1987). Chronic Vaginal Candidiasis in Women With Human Immunodeficiency Virus Infection. JAMA
257: 3105-3107
[Abstract]
Conant, M. A.
(1987). Hairy Leukoplakia: A New Disease of the Oral Mucosa. Arch Dermatol
123: 585-587
[Abstract]
Lupton, G. P., James, W. D., Redfield, R. R., Brown, C., Rodman, O. G.
(1987). Oral Hairy Leukoplakia: A Distinctive Marker of Human T-Cell Lymphotropic Virus Type III (HTLV-III) Infection. Arch Dermatol
123: 624-628
[Abstract]
Kaplan, L. D., Wofsy, C. B., Volberding, P. A.
(1987). Treatment of Patients With Acquired Immunodeficiency Syndrome and Associated Manifestations. JAMA
257: 1367-1374
[Abstract]
Lang, W., Anderson, R. E., Perkins, H., Grant, R. M., Lyman, D., Winkelstein, W. Jr, Royce, R., Levy, J. A.
(1987). Clinical, Immunologic, and Serologic Findings in Men at Risk for Acquired Immunodeficiency Syndrome: The San Francisco Men's Health Study. JAMA
257: 326-330
[Abstract]
Mayer, K. H.
(1986). The Clinical Challenges of AIDS and HIV Infection. J Law Med Ethics
14: 281-289
CLOTET, B., GRIFOL, M., PARRA, O., BOIX, J., JUNCA, J., TOR, J., FOZ, M.
(1986). Asymptomatic Esophageal Candidiasis in the Acquired-Immunodeficiency- Syndrome-Related Complex. ANN INTERN MED
105: 145-145
[Abstract]
PAIETTA, E., SALTZMAN, B., KLEIN, R. S., FRIEDLAND, G. H., WIERNIK, P. H., STEIN, H.
(1986). Expression of Activation Antigen on Lymphocytes in the Acquired Immunodeficiency Syndrome. ANN INTERN MED
104: 890-891
[Abstract]
Fishbein, D. B., Kaplan, J. E., Spira, T. J., Miller, B., Schonberger, L. B., Pinsky, P. F., Getchell, J. P., Kalyanaraman, V. S., Braude, J. S.
(1985). Unexplained Lymphadenopathy in Homosexual Men: A Longitudinal Study. JAMA
254: 930-935
[Abstract]
JAFFE, H. W., DARROW, W. W., ECHENBERG, D. F., O'MALLEY, P. M., GETCHELL, J. P., KALYANARAMAN, V. S., BYERS, R. H., DRENNAN, D. P., BRAFF, E. H., CURRAN, J. W., FRANCIS, D. P.
(1985). The Acquired Immunodeficiency Syndrome in a Cohort of Homosexual Men: A Six-Year Follow-up Study. ANN INTERN MED
103: 210-214
[Abstract]
GROOPMAN, J. E., MAYER, K. H., SARNGADHARAN, M. G., AYOTTE, D., DEVICO, A. L., FINBERG, R., SLISKI, A. H., ALLAN, J. D., GALLO, R. C.
(1985). Seroepidemiology of Human T-Lymphotropic Virus Type III Among Homosexual Men with the Acquired Immunodeficiency Syndrome or Generalized Lymphadenopathy and Among Asymptomatic Controls in Boston. ANN INTERN MED
102: 334-337
[Abstract]
Previous
